Company News 31 Jan 2022 Quarterly Report – Period To December 2021 Orthocell (ASX $OCC) has today published its Quarterly Report for the period ended 31 December 2021. Orthocell
Media 13 Dec 2021 RADIO INTERVIEW | Bulls N’ Bears Report Orthocell (ASX $OCC) MD, Paul Anderson, was interviewed by Matt Birney on the Bulls N’ Bears Report about our latest… Orthocell
Media 09 Dec 2021 The West Australian | Orthocell’s tendon injury treatment a game-changer, clinical trial finds Orthocell (ASX $OCC) has been featured in The West Australian in a story titled, “Orthocell’s tendon injury treatment a game-changer, clinical trial… Orthocell
Company News 08 Dec 2021 Positive clinical results for OrthoATI™ Orthocell (ASX $OCC) has today released positive clinical data for its OrthoATI™ tendon program, which shows that OrthoATI™ is statistically more… Orthocell
Company News 15 Nov 2021 Ortho-ATI® Update Orthocell (ASX $OCC) has today released an update on its Ortho-ATI™ rotator cuff tendon study – the database is now… Orthocell
Company News 28 Oct 2021 Orthocell featured as a Case Study in the Australian Regenerative Medicine Therapies Report Orthocell’s CelGro™ technology has been featured as one of only four case studies in the recent Australian Regenerative Medicine Therapies… Orthocell
Company News 28 Oct 2021 Investor Presentation | Canaccord Genuity South-West Connect ASX Showcase Orthocell MD, Paul Anderson, presented at the Canaccord Genuity South-West Connect ASX Showcase today to share the latest news and… Orthocell
Media 15 Sep 2021 Orthocell (ASX:OCC) announces positive data on CelGro collagen rope for ACL repair Orthocell has been featured in The Market Herald, following our announcement of positive data from a pre-clinical study for anterior… Orthocell
Media 07 Sep 2021 Orthocell (ASX:OCC) granted patents in Canada and Hong Kong for CelGro Orthocell has been featured in The Market Herald, following our announcement of patents granted in Canada and Hong Kong for… Orthocell
Media, Video 02 Sep 2021 Video | Proactive Investors – September 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
